Article Per Year (5 Year)
p-Index From 2021 - 2026
1.556
P-Index
This Author published in this journals
All Journal Indonesian Journal of Clinical Pathology and Medical Laboratory (IJCPML) SURABAYA PHYSICAL MEDICINE AND REHABILITATION JOURNAL Majalah Biomorfologi (Biomorphology Journal) Cardiovascular and Cardiometabolic Journal (CCJ) Indian Journal of Forensic Medicine & Toxicology Journal Pharmasci (Journal of Pharmacy and Science) AKSONA Cerdika: Jurnal Ilmiah Indonesia International Journal Of Health And Social Behavior
Putranto, J.Nugroho Eko
Department Of Cardiology And Vascular Medicine, Faculty Of Medicine, Universitas Airlangga, RSUD Dr. Soetomo, Surabaya, Indonesia
Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Economics, Econometrics & Finance Education Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences

Published : 11 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 11 Documents
Search

 1   2 
Profile of Acute Coronary Syndrome Patients with Hypertension Receiving ARB/ACEI Therapy at ICCU RSUD Dr. Soetomo Purwaningsih , Sri; Yusuf, Mochamad; Putranto, Johanes Nugroho Eko; Sudanawidjaja, Melisa Nathania
International Journal of Health and Social Behavior Vol. 3 No. 1 (2026): February: International Journal of Health and Social Behavior
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62951/ijhsb.v3i1.601

Abstract

Hypertension is a major modifiable risk factor contributing to the development of Acute Coronary Syndrome (ACS), which includes STEMI, NSTEMI, and unstable angina. The increasing prevalence of hypertension worldwide raises concern regarding its impact on cardiovascular outcomes. This study aimed to describe the profile of ACS patients with hypertension receiving angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) therapy in the Intensive Coronary Care Unit (ICCU) of RSUD Dr. Soetomo Surabaya. Using a descriptive cross-sectional method, data from 91 patients treated between July 2021 and October 2024 were analyzed. Variables included demographic characteristics, clinical classification of ACS, hypertension degree, comorbidities, types and doses of ACEI/ARB administered. The results showed that most patients were male (73%) and aged over 65 years (40%). Chi-square analysis revealed no significant relationship between hypertension degree, ACS classification, or most comorbidities with drug selection or dosage (p>0.05), except for a significant association between coronary heart disease comorbidity and ARB selection. These findings suggest that in hypertensive ACS patients, the choice between ACEI and ARB therapy is predominantly based on individual comorbidity profiles rather than blood pressure severity or ACS type. The study highlights the importance of personalized treatment approaches considering patient comorbidities to optimize cardiovascular outcomes.
Co-Authors Abdul Rahman Bahmid Agus Subagjo Andrianus Oktovianto Budi Suprapti Charliandri Saputra Wahab Cicilia Indriaty Denny Suwanto Fhahira Rizkhika Admadiani Irwadi, Irfiansyah Kusmiati, Tutik Leonita Anniwati Mochamad Yusuf Alsagaff Ni Made Mertaniasih Ni Putu Anggun Laksmi Ogiska Chaherfa Nadasya Purwaningsih , Sri Ramadhan, Muhammad Qashmal Rifqi, Muhammad Andika Rina Mawarti Rochmawati, Ike Dhiah S. Soedarsono S.Pd. M Kes I Ketut Sudiana . Sita Setyowatie Soebroto, Heroe Soemantri, Djoko Sudanawidjaja, Melisa Nathania Suprabawati, Desak Gede Agung Yogiarto, Mohammad